Bailard »

Protalix Biotherapeutics shares owned by Bailard

Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by Bailard from 13F filings

Historical chart of Bailard investment in Protalix Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protalix Biotherapeutics held by Bailard consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protalix Biotherapeutics by Bailard

Quarter filed Position value Share count Share price at filing
2026-06-30 $142k 61k 2.33
2023-12-31 $121k 68k 1.78

More positions owned by Bailard

Apple (AAPL)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Ishares Tr Msci Eafe Etf (EFA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard World Inf Tech Etf (VGT)
Ishares Tr Rus 2000 Val Etf (IWN)
Gilead Sciences (GILD)
Ishares Tr Core Msci Eafe (IEFA)
J P Morgan Exchange Traded F Mortgage Backed (JMTG)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Calif Mun Bd Etf (CMF)
Amazon (AMZN)

View all positions for Bailard

Top funds holding Protalix Biotherapeutics

BlackRock
MAK Capital One
Renaissance Technologies
State Street Corporation
Northern Trust
Geode Capital Management
Stratos Wealth Partners
Vanguard Portfolio Management
Prospera Financial Services
Opaleye Management
Morgan Stanley
Dimensional Fund Advisors
OTR - Nominee Name for The State Teachers Retirement Board of Ohio
Susquehanna International
UBS Group

View all funds holding Protalix Biotherapeutics